Metastatic Triple-Negative Breast Cancer: Kurapwa Kutsva

 Everest Medicines, kambani yebiopharmaceutical yakatarisana nekugadzira nekutengesa zvinoshandura mishonga yemishonga kugadzirisa zvinodikanwa zvisingaite mumisika yeAsia Pacific, yakazivisa nhasi kuti Health Sciences Authority (HSA) yekuSingapore yabvumidza Trodelvy® (sacituzumab govitecan kana SG) kurapwa Varwere vakura vane chirwere chegomarara chemuzamu chepamusoro kana metastatic katatu-negative (mTNBC) vakagamuchira maviri kana anopfuura ekutanga maitiro ekurapa, angangoita imwe chete yechirwere chemetastatic. Izvi zvinoratidza mvumo yekutanga yemishonga yeTrodelvy yakagamuchirwa naEverest. Iyo Kambani inotarisira nhevedzano yemvumo yeTrodelvy munzvimbo dzayo rezinesi mugore rinouya.

"Sechikamu chehurongwa hwedu hombe hwebhizinesi rekuvaka kutengeserana kwakasimba mumisika yeAsia Pacific, isu takanyatso kugadzikana kuti tikurumidze kukurumidza panguva ino inotevera chikamu chekukura neboka rakagadzwa revatengesi, kuvharira musiyano pakati pevarwere vane zvinodiwa zvekurapwa zvisingaite uye kutanga. -in-class biopharmaceutical innovation, "akadaro Kerry Blanchard, MD, PhD, Chief Executive Officer weEverest Medicines. "Sedanho rinotevera tichange tichishanda takabatana nevose vane chekuita nekuunza Trodelvy kuvakadzi muSingapore vanorarama neTNBC metastatic." 

“TNBC ine chikamu che15-20% chevanhu vose vane gomarara rezamu muSingapore, uye gomarara rezamu ndiro riri kukonzera kufa kwegomarara muvanhukadzi munyika. Iyi nzira ine hukasha uye yakaoma-kurapa yechirwere yakagara iine nzira shoma dzekurapa, nekupona kwese kwasara kusachinja pakati pevarwere kweanoda kusvika makumi maviri emakore, "akadaro Yang Shi, Chief Medical Officer weOncology kuEverest Medicines. Ichi chiitiko chekutonga chinounza Trodelvy nhanho imwe pedyo nevarwere veSingapore vane metastatic TNBC. "

Pamusoro peSingapore, Everest iri kudyidzana zvakanyanya nemasangano anodzora muGreater China neSouth Korea kuti aongorore manyorerwo ayo eTrodelvy kuvarwere vakura vane TNBC isingatarisike munharaunda kana metastatic TNBC vakagamuchira maviri kana anopfuura ekutanga maitiro ekurapa. chirwere che metastatic.

• Muna Chivabvu 2021, China National Medical Products Administration yakatambira Chikumbiro chayo cheBiologics Rezinesi reTrodelvy nechinangwa chekuongorora.

• Muna Zvita 2021, Ministry of Food and Drug Safety (MFDS) yekuSouth Korea yakatambira New Drug Application (NDA) yeTrodelvy. Trodelvy akambopihwa Fast Track Dhizaini uye Nherera Zvinodhaka Dhizaini muSouth Korea.

• Muna Zvita 2021, Taiwan Food and Drug Administration yakagamuchira NDA yayo yeTrodelvy. Trodelvy yakambopihwa Pediatric uye Rare Severe Severe Chirwere Chekutanga Ongororo Dhizaini muTaiwan.